Takeda Pharmaceutical Co Ltd: Form 20-F for the period ended Mar 31, 2024
Filed with the SEC on Jun 26, 2024 and accepted by EDGAR at Jun 26, 2024, 06:07 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-04-01 to 2024-03-31 | JPY 4.26tn | ifrs-full:Revenue |
| Cost of revenue | 12 months2023-04-01 to 2024-03-31 | JPY 1.43tn | ifrs-full:CostOfSales |
| Operating income | 12 months2023-04-01 to 2024-03-31 | JPY 214.07bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2023-04-01 to 2024-03-31 | −JPY 91.41bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2023-04-01 to 2024-03-31 | JPY 144.07bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months2023-04-01 to 2024-03-31 | JPY 91.16 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2023-04-01 to 2024-03-31 | JPY 92.09 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2023-04-01 to 2024-03-31 | JPY 716.34bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2023-04-01 to 2024-03-31 | JPY 175.42bn | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2024-03-31 | JPY 457.80bn | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2024-03-31 | JPY 2.56tn | ifrs-full:CurrentAssets |
| Total assets | At period end2024-03-31 | JPY 15.11tn | ifrs-full:Assets |
| Current liabilities | At period end2024-03-31 | JPY 2.31tn | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2024-03-31 | JPY 7.83tn | ifrs-full:Liabilities |
| Shareholders' equity | At period end2024-03-31 | JPY 7.27tn | ifrs-full:EquityAttributableToOwnersOfParent |
Source: SEC EDGAR, the filing index for accession 0001395064-24-000086. Last ingested by Listed: Nov 5, 2026, 16:17 ET. Listed shows no prices and gives no investment advice.